HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanne G S Verberk Selected Research

ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)

12/2021The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis.
6/2021Myeloid-Specific Acly Deletion Alters Macrophage Phenotype In Vitro and In Vivo without Affecting Tumor Growth.
12/2020Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sanne G S Verberk Research Topics

Disease

3Inflammation (Inflammations)
12/2021 - 09/2020
2Atherosclerotic Plaque (Atheroma)
05/2022 - 12/2020
1Atherosclerosis
12/2021
1Neoplasms (Cancer)
06/2021
1Carcinogenesis
06/2021
1Peritonitis
01/2021

Drug/Important Bio-Agent (IBA)

3LipidsIBA
12/2021 - 12/2020
3ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA
12/2021 - 12/2020
1CD40 Ligand (CD40L)IBA
05/2022
1LigandsIBA
05/2022
1Pharmaceutical PreparationsIBA
12/2021
1Acetyl Coenzyme A (Acetyl-CoA)IBA
06/2021
1PlasticsIBA
01/2021
1EndotoxinsIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Succinic Acid (Succinate)IBA
09/2020

Therapy/Procedure

2Therapeutics
12/2021 - 06/2021